Poster Session 3-7 Eldely AML

Sun. Oct 14, 2018 12:40 PM - 1:20 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Yuho Najima (Tokyo Metropolitan Cancer and Infections Diseases Center, Komagome Hospital)

+Add all to schedule

[PS3-7-1] Decitabine versus intensive chemotherapy for treatment of elderly acute myeloid leukemia patients

Eun-Ji Choi, Je-Hwan Lee, Jung-Hee Lee, Han-Seung Park, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ji Min Woo, Kyoo-Hyung Lee (Hematology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Republic of Korea)

[PS3-7-2] The risk of early mortality in the elderly patients with newly diagnosed acute myeloid leukemia

Chia-Jen Liu¹, Ying-Chung Hong², Chung-Jen Teng³, Po-Shen Ko¹, Yao-Chung Liu¹, Hao-Yuan Wang¹, Liang-Tsai Hsiao¹, Tzeon-Jye Chiou⁴, Jin-Hwang Liu⁵, Po-Min Chen¹, Jyh-Pyng Gau¹ (1.Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, 2.Division of Hematology and Oncology, Kaohsiung Taipei Veterans General Hospital, Kaohsiung, Taiwan, 3.Division of Oncology and Hematology, Department of Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan, 4.Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, 5.Chong Hin Loon Cancer and Biotherapy Research Institute, National Yang-Ming University, Taipei, Taiwan)

[PS3-7-3] A retrospective analysis of acute myelogenous leukemia in patients > 65 years of age, with dementia

Kei Fujita, Eiju Negoro, Shin Lee, Kana Oiwa, Miyuki Ookura, Yasufumi Matsuda, Katsunori Tai, Naoko Hosono, Takanori Ueda, Takahiro Yamauchi (Department of Hematology and Oncology, University of Fukui)

[PS3-7-4] Dose adjustment of daunorbicin in induction therapy for elderly patients with acute myeloid leukemia

Hiroto Ishii¹, Yuko Shiota¹, Rie Ohba¹, Aya Nakano^1,2, Ryoko Fukushima^1,2, Hirofumi Yamauchi¹, Mamiko Momoki¹, Noriko Usui¹, Nobuaki Dobashi¹, Shingo Yano² (1.Clin. Oncol. and Hematol, Jikei University Daisan Hospital, Tokyo, Japan, 2.Clin. Oncol. and Hematol, Jikei University Hospital, Tokyo, Japan)

[PS3-7-5] Clinical features and treatment outcome of AML patients over 75 years old at our hospital

Michiko Kida, Miki Kido, Takuo Ito (Dept. Hematology, Kure Medical Center, Kure, Japan)

[PS3-7-6] Clinical analysis of treatment for elderly patients with acute myeloid leukemia

Akane Kaihatsu¹, Syun Uemura², Hironori Kobayashi², Kyoko Fuse³, Nobuhiko Nomoto² (1.Hematol, Niigata Univ, Niigata, Japan, 2.Internal medicine, Shibata hospital, Niigata, Japan, 3.Community medicine, Niigata Univ, Niigata, Japan)

[PS3-7-7] Impact of azacytidine for oligoblastic AML ineligible for stem cell transplantation

Gaku Oshikawa¹, Yoshihiro Umezawa², Aiko Igarashi³, Kazuhiko Kakihana³, Kazuteru Ohashi³, Norihiko Kawamata², Osamu Miura², Masahide Yamamoto² (1.Department of Hematology, Musashino Red Cross Hospital, Tokyo, Japan, 2.Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan, 3.Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Japan)